Russell Investments Group, Ltd. - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 87 filers reported holding UROGEN PHARMA LTD in Q2 2023. The put-call ratio across all filers is 2.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$3,545
+35.4%
2530.0%0.00%
Q2 2023$2,619
+12.0%
2530.0%0.00%
Q1 2023$2,338
-85.4%
253
-87.1%
0.00%
Q2 2022$16,000
-5.9%
1,9620.0%0.00%
Q1 2022$17,000
-5.6%
1,9620.0%0.00%
Q4 2021$18,000
-98.1%
1,962
-96.6%
0.00%
-100.0%
Q3 2021$958,000
+10.5%
56,997
+0.2%
0.00%
+100.0%
Q2 2021$867,000
+31.4%
56,876
+67.5%
0.00%0.0%
Q1 2021$660,000
-35.9%
33,953
-40.7%
0.00%
-50.0%
Q4 2020$1,030,000
+765.5%
57,221
+2168.0%
0.00%
Q3 2018$119,0002,5230.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 900,148$23,512,0008.12%
Horton Capital Management, LLC 383,428$10,015,0007.55%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$77,177,0001.89%
Phoenix Holdings Ltd. 897,464$22,251,0000.94%
SHIKIAR ASSET MANAGEMENT INC 51,175$1,337,0000.61%
Migdal Insurance & Financial Holdings Ltd. 738,302$19,284,0000.31%
Coastal Bridge Advisors, LLC 37,000$966,0000.31%
Clal Insurance Enterprises Holdings Ltd 529,388$13,828,0000.27%
ALGERT GLOBAL LLC 10,880$284,0000.10%
BANK HAPOALIM BM 14,831$387,0000.09%
View complete list of UROGEN PHARMA LTD shareholders